ArticleCPT: pharmacometrics & systems pharmacology2020

Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis-Associated Pain: An Application of Markov Model.

Insa Winzenborg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.